Use of Teplizumab to Modulate Stage 2 Type 1 Diabetes in Two Individuals With Autoimmune Polyendocrine Syndrome 1
使用替普利珠单抗调节两例自身免疫性多内分泌综合征患者的 2 期 1 型糖尿病 1
期刊:
影响因子:
doi:10.2337/dc25-1444
Wilson, Christopher S; Falk, Alexander; Williams, Jonathan M; Hilmes, Melissa; Ross, Jordan; LeStourgeon, Lauren; Haller, Michael J; Drawdy, Martina; Pechacek, Joseph; Webb, Taura; Diaz-Thomas, Alicia; Russell, William E; Gregory, Justin M; Virostko, Jack; Lionakis, Michail S; Moore, Daniel J